146 related articles for article (PubMed ID: 9732993)
21. An example of the detection of an esophageal carcinoma in its very early stage by urinary xanthopterin determination.
Iino T; Watanabe H; Gyure WL; Mazda T; Mieno H; Tsusué M
Adv Exp Med Biol; 1993; 338():243-6. PubMed ID: 8304117
[No Abstract] [Full Text] [Related]
22. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
[TBL] [Abstract][Full Text] [Related]
23. Tumor-associated trypsin inhibitor (TATI) in benign and malignant gastric disease.
Loizate Toricaguena A; Lamiquiz Vallejo A; Dominguez Merru-Urrutia MJ; Legorburu Escudero JF
Scand J Clin Lab Invest Suppl; 1991; 207():59-62. PubMed ID: 1780694
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.
Kosugi S; Nishimaki T; Kanda T; Nakagawa S; Ohashi M; Hatakeyama K
World J Surg; 2004 Jul; 28(7):680-5. PubMed ID: 15383868
[TBL] [Abstract][Full Text] [Related]
25. Tumour markers and their prognostic value in adenocarcinoma of the cervix.
Ngan HY; Cheung AN; Lauder IJ; Cheng DK; Wong LC; Ma HK
Tumour Biol; 1998; 19(6):439-44. PubMed ID: 9817971
[TBL] [Abstract][Full Text] [Related]
26. Tumor markers in hemodialysis patients.
Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
[No Abstract] [Full Text] [Related]
27. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer.
Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G
Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417
[TBL] [Abstract][Full Text] [Related]
30. Measurement of four tumor marker antigens in the sera of pregnant women.
Cheli CD; Morris DL; Neaman IE; Dai J; Allard WJ; Yeung KK
J Clin Lab Anal; 1999; 13(1):35-9. PubMed ID: 10025736
[TBL] [Abstract][Full Text] [Related]
31. Tumor markers in patients with chronic renal failure.
Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated trypsin inhibitor, TATI, in gastrointestinal cancer and related benign diseases.
Piantino P; Arosaio E
Scand J Clin Lab Invest Suppl; 1991; 207():67-9. PubMed ID: 1780697
[TBL] [Abstract][Full Text] [Related]
33. PAULA's Test for Lung Cancer Screening.
Clebak KT; Partin MT; Mendez-Miller M
Am Fam Physician; 2020 Jul; 102(1):53-54. PubMed ID: 32603076
[No Abstract] [Full Text] [Related]
34. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
[TBL] [Abstract][Full Text] [Related]
36. Serum SCC-Ag in head and neck squamous cell carcinoma.
Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
38. [Serum pancreatic enzymes and enzyme inhibitor as a tumor marker for pancreatic cancer].
Ogawa M
Rinsho Byori; 1986 Nov; 34(11):1229-35. PubMed ID: 2434691
[No Abstract] [Full Text] [Related]
39. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.
Cheah PL; Liam CK; Yap SF; Looi LM
J Clin Pathol; 1994 Jun; 47(6):535-7. PubMed ID: 8063936
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients.
Jezersek B; Cervek J; Rudolf Z; Novaković S
Cancer Lett; 1996 Dec; 110(1-2):137-44. PubMed ID: 9018092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
